1-deoxynojirimycin has been researched along with sphingosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Grabowski, GA; Greenberg, P; Liotta, DC; Merrill, AH | 1 |
| Desnick, RJ; Fabbro, D; Grabowski, GA; Legler, G; Osiecki-Newman, K | 1 |
| Deckelbaum, RJ; Juliano, RA; Seo, T; Worgall, TS | 1 |
| Bryan, C; Crooks, A; Ding, W; Dingemanse, J; O'Donnell, P; Prociuk, M; Sikora, T; Stein, VM; Vanier, MT; Vite, CH; Walkley, SU | 1 |
| Benjamin, ER; Boudes, P; Brignol, N; Chang, HH; Fuller, M; Germain, DP; Giugliani, R; Hughes, DA; Khanna, R; Lockhart, DJ; Mehta, A; Nicholls, K; Sitaraman, SA; Soska, R; Valenzano, KJ; Young-Gqamana, B | 1 |
| Andreotti, G; Bräuer, AU; Cimmaruta, C; Citro, V; Cozma, C; Cubellis, MV; Ernst, M; Fuellen, G; Giese, AK; Haake, LR; Hermann, A; Knospe, AM; Koczan, D; Lukas, J; Rolfs, A; Seemann, S; Struckmann, S | 1 |
6 other study(ies) available for 1-deoxynojirimycin and sphingosine
| Article | Year |
|---|---|
Human acid beta-glucosidase: use of sphingosyl and N-alkyl-glucosylamine inhibitors to investigate the properties of the active site.
Topics: 1-Deoxynojirimycin; Binding Sites; Female; Glucosamine; Glucosidases; Glucosylceramidase; Humans; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Pregnancy; Protein Conformation; Sphingosine | 1990 |
Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
Topics: 1-Deoxynojirimycin; Amines; beta-Glucosidase; Binding Sites; Binding, Competitive; Ceramides; Female; Gaucher Disease; Glucosamine; Glucosidases; Glucosides; Humans; Kinetics; Octoxynol; Placenta; Polyethylene Glycols; Pregnancy; Sphingosine; Spleen; Structure-Activity Relationship | 1987 |
Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein.
Topics: 1-Deoxynojirimycin; Acyltransferases; Amidohydrolases; Animals; CCAAT-Enhancer-Binding Proteins; Ceramides; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Cycloserine; DNA-Binding Proteins; Enzyme Induction; Fatty Acids, Monounsaturated; Fumonisins; Genes, Reporter; Hydroxymethylglutaryl-CoA Synthase; Morpholines; Myristates; Phosphotransferases (Alcohol Group Acceptor); Propanolamines; RNA Processing, Post-Transcriptional; Serine C-Palmitoyltransferase; Sphingolipids; Sphingosine; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Transcription, Genetic; Transfection | 2004 |
Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C.
Topics: 1-Deoxynojirimycin; Animals; Antigens, CD; Area Under Curve; Brain; Case-Control Studies; Cat Diseases; Cats; Cell Survival; Cholesterol; Enzyme Inhibitors; Follow-Up Studies; Gangliosidoses, GM2; Microglia; Niemann-Pick Disease, Type C; Phagocytosis; Phenotype; Postmortem Changes; Purkinje Cells; Reactive Oxygen Species; Sphingomyelins; Sphingosine; Time Factors | 2012 |
Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.
Topics: 1-Deoxynojirimycin; Administration, Oral; alpha-Galactosidase; Animals; Fabry Disease; Glycolipids; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Reproducibility of Results; Sphingolipids; Sphingosine; Trihexosylceramides | 2013 |
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Biomarkers; Endoplasmic Reticulum; Fabry Disease; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Lysosomal Storage Diseases; Lysosomes; Mutation, Missense; Proteasome Endopeptidase Complex; Protein Transport; Proteostasis; Sphingosine | 2020 |